These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 9092419)
1. [Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors]. Rosa A; Canaple S Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1563-8. PubMed ID: 9092419 [TBL] [Abstract][Full Text] [Related]
2. Combination antiplatelet agents in ischemic cerebrovascular disease. Moussouttas M; Papamitsakis N Mt Sinai J Med; 2005 Jan; 72(1):16-22. PubMed ID: 15682258 [TBL] [Abstract][Full Text] [Related]
5. Ticlopidine or clopidogrel as alternatives to aspirin in prevention of ischemic stroke. Bendixen BH; Adams HP Eur Neurol; 1996; 36(5):256-7. PubMed ID: 8864703 [No Abstract] [Full Text] [Related]
6. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
7. Antiplatelet agents and stroke prevention. Dyken ML Semin Neurol; 1998; 18(4):441-50. PubMed ID: 9932615 [TBL] [Abstract][Full Text] [Related]
10. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke. Pongrácz E Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
12. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Bhatt DL; Topol EJ; Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents for prevention of recurrent ischemic stroke. Hegge KA S D Med; 2009 Jan; 62(1):15-7. PubMed ID: 19245087 [TBL] [Abstract][Full Text] [Related]
15. Low- versus high-dose aspirin in prevention of ischemic stroke. Adams HP; Bendixen BH Clin Neuropharmacol; 1993 Dec; 16(6):485-500. PubMed ID: 9377584 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet drugs in secondary prevention of stroke. Diener HC Int J Clin Pract; 1998 Mar; 52(2):91-7. PubMed ID: 9624789 [TBL] [Abstract][Full Text] [Related]
18. [Prevention of thrombosis after ischemic cerebrovascular attack--new possibilities]. Boysen G Ugeskr Laeger; 1998 Jul; 160(30):4432-3. PubMed ID: 9691838 [No Abstract] [Full Text] [Related]
19. [Preventive treatment of cerebrovascular accidents of arterial origin]. Castillo V; Bogousslavsky J; Vuadens P Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178 [TBL] [Abstract][Full Text] [Related]
20. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?]. Einecke D MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244 [No Abstract] [Full Text] [Related] [Next] [New Search]